High-risk population for gastric cancer development based on serum pepsinogen status and lifestyle factors

Helicobacter

Volumn 14, Issue 2, 2009, Pages 81-86

  Yamaji, Yutaka ^a   Watabe, Hirotsugu ^a   Yoshida, Haruhiko ^a   Kawabe, Takao ^a   Wada, Ryoichi ^b,c   Mitsushima, Toru ^b,c   Omata, Masao ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b Kameda General Hospital   (Japan)

^c Makuhari Clinic   (Japan)

Author keywords

Alcohol drinking; Helicobacter pylori; Obesity; Pepsinogen; Smoking; Stomach Neoplasms

Indexed keywords

BACTERIUM ANTIBODY; PEPSINOGEN;

ADULT; ALCOHOL CONSUMPTION; ANTIBODY BLOOD LEVEL; ARTICLE; ATROPHY; BODY HEIGHT; BODY MASS; BODY WEIGHT; CANCER INCIDENCE; CANCER RISK; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER PYLORI; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; SMOKING HABIT; STOMACH CANCER;

ADULT; ALCOHOL DRINKING; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; JAPAN; LIFE STYLE; MALE; MIDDLE AGED; PEPSINOGEN A; PROSPECTIVE STUDIES; RISK FACTORS; SMOKING; STOMACH NEOPLASMS;

HELICOBACTER PYLORI;

EID: 62149123977     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2009.00665.x     Document Type: Article

References (43)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005 55 : 74 108.
2. Forman D, Newell DG, Fullerton F, Yarnell JW, Stacey AR, Wald N, Sitas F. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. BMJ 1991 302 : 1302 5.
3. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, Sibley RK. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991 325 : 1127 31.
4. Nomura A, Stemmermann GN, Chyou PH, Kato I, Perez-Perez GI, Blaser MJ. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991 325 : 1132 6.
5. The Eurogast Study Group. An international association between Helicobacter pylori infection and gastric cancer. Lancet 1993 341 : 1359 62.
6. International Agency for Research on Cancer. Infection with Helicobacter pylori. In : IARC Monographs on the Evaluation of the Carcinogenic Risks to Humans (Vol. 61). Schistosomes, liver flukes and Helicobacter pylori. Lyon, France : International Agency for Research on Cancer, 1994 177 241.
7. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001 345 : 784 9.
8. Leung WK, Wu M-s, Kakugawa Y, et al. Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol 2008 9 : 279 87.
9. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process - First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992 52 : 6735 40.
10. Yamaji Y, Mitsushima T, Ikuma H, Okamoto M, Yoshida H, Kawabe T, Shiratori Y, Saito K, Yokouchi K, Omata M. Inverse background of Helicobacter pylori antibody and pepsinogen in reflux oesophagitis compared with gastric cancer: analysis of 5732 Japanese subjects. Gut 2001 49 : 335 40.
11. Graham DY, Shiotani A. The time to eradicate gastric cancer is now. Gut 2005 54 : 735 8.
12. Watabe H, Mitsushima T, Yamaji Y, Okamoto M, Wada R, Kokubo T, Doi H, Yoshida H, Kawabe T, Omata M. Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study. Gut 2005 54 : 764 8.
13. Joint WHO/FAO Expert Consultation on Diet, Nutrition and the Prevention of Chronic Diseases. Diet, nutrition and the prevention of chronic diseases: report of a joint WHO/FAO expert consultation. WHO Technical Report Series 916. Geneva : World Health Organization, 2003.
14. World Cancer Research Fund / American Institute for Cancer Research Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. Washington DC : American Institute for Cancer Research, 2007.
15. Tredaniel J, Boffetta P, Buiatti E, Saracci R, Hirsch A. Tobacco smoking and gastric cancer: review and meta-analysis. Int J Cancer 1997 72 : 565 73.
16. Sasazuki S, Sasaki S, Tsugane S, Japan Public Health Center Study G. Cigarette smoking, alcohol consumption and subsequent gastric cancer risk by subsite and histologic type. Int J Cancer 2002 101 : 560 6.
17. Nishino Y, Inoue M, Tsuji I, Wakai K, Nagata C, Mizoue T, Tanaka K, Tsugane S, Research Group for the Development and Evaluation of Cancer Prevention Strategies in Japan. Tobacco smoking and gastric cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol 2006 36 : 800 7.
18. Sung NY, Choi KS, Park EC, Park K, Lee SY, Lee AK, Choi IJ, Jung KW, Won YJ, Shin HR. Smoking, alcohol and gastric cancer risk in Korean men: the National Health Insurance Corporation Study. Br J Cancer 2007 97 : 700 4.
19. Shimazu T, Tsuji I, Inoue M, Wakai K, Nagata C, Mizoue T, Tanaka K, Tsugane S, Research Group for the Development and Evaluation of Cancer Prevention Strategies in Japan. Alcohol drinking and gastric cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol 2008 38 : 8 25.
20. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003 348 : 1625 38.
21. Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D, Million Women Study Collaborators. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ 2007 335 : 1134 44.
22. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008 371 : 569 78.
23. Cowey S, Hardy RW. The metabolic syndrome: a high-risk state for cancer? Am J Pathol 2006 169 : 1505 22.
24. Giovannucci E, Michaud D. The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas. Gastroenterology 2007 132 : 2208 25.
25. Ji BT, Chow WH, Yang G, Mclaughlin JK, Gao RN, Zheng W, Shu XO, Jin F, Fraumeni JF Jr., Gao YT. Body mass index and the risk of cancers of the gastric cardia and distal stomach in Shanghai, China. Cancer Epidemiol Biomarkers Prev 1997 6 : 481 5.
26. Chow WH, Blot WJ, Vaughan TL, et al. Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 1998 90 : 150 5.
27. Crabtree JE, Shallcross TM, Heatley RV, Wyatt JI. Evaluation of a commercial ELISA for serodiagnosis of Helicobacter pylori infection. J Clin Pathol 1991 44 : 326 8.
28. Sakaki N. Helicobacter pylori and gastric cancer in view of relation to atrophy of background gastric mucosa. [In Japanese]. Nippon Rinsho - Jap J Clin Med 1993 51 : 3242 7.
29. Miki K, Ichinose M, Shimizu A, Huang SC, Oka H, Furihata C, Matsushima T, Takahashi K. Serum pepsinogens as a screening test of extensive chronic gastritis. Gastroenterol Jpn 1987 22 : 133 41.
30. Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH, Stemmermann GN, Nomura A. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995 55 : 2111 5.
31. Ogura K, Kanai F, Maeda S, Yoshida H, Ogura M, Lan KH, Hirota K, Kawabe T, Shiratori Y, Omata M. High prevalence of cytotoxin positive Helicobacter pylori in patients unrelated to the presence of peptic ulcers in Japan. Gut 1997 41 : 463 8.
32. International Agency for Research on Cancer. IARC monographs on the evaluation of the carcinogenic risks to humans, 83. Tobacco Smoke and Involuntary Smoking. Lyon: International Agency for Research on Cancer 2004.
33. Machida-Montani A, Sasazuki S, Inoue M, Natsukawa S, Shaura K, Koizumi Y, Kasuga Y, Hanaoka T, Tsugane S. Association of Helicobacter pylori infection and environmental factors in non-cardia gastric cancer in Japan. Gastric Cancer 2004 7 : 46 53.
34. Kikuchi S, Nakajima T, Kobayashi O, et al. U-shaped effect of drinking and linear effect of smoking on risk for stomach cancer in Japan. Jpn J Cancer Res 2002 93 : 953 9.
35. Siman JH, Forsgren A, Berglund G, Floren CH. Tobacco smoking increases the risk for gastric adenocarcinoma among Helicobacter pylori-infected individuals. Scand J Gastroenterol 2001 36 : 208 13.
36. Inoue M, Tajima K, Hirose K, Kuroishi T, Gao CM, Kitoh T. Life-style and subsite of gastric cancer - joint effect of smoking and drinking habits. Int J Cancer 1994 56 : 494 9.
37. Tsugane S, Sasazuki S, Kobayashi M, Sasaki S. Salt and salted food intake and subsequent risk of gastric cancer among middle-aged Japanese men and women. Br J Cancer 2004 90 : 128 34.
38. Azuma T, Suto H, Ito Y, Muramatsu A, Ohtani M, Dojo M, Yamazaki Y, Kuriyama M, Kato T. Eradication of Helicobacter pylori infection induces an increase in body mass index. Aliment Pharmacol Ther 2002 16 : 240 4.
39. Labenz J, Blum AL, Bayerdorffer E, Meining A, Stolte M, Borsch G. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 1997 112 : 1442 7.
40. Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002 288 : 1723 7.
41. Yamaji Y, Mitsushima T, Yoshida H, Watabe H, Okamoto M, Wada R, Ikuma H, Kawabe T, Omata M. The malignant potential of freshly developed colorectal polyps according to age. Cancer Epidemiol Biomarkers Prev 2006 15 : 2418 21.
42. Ogura K, Hirata Y, Yanai A, et al. The effect of Helicobacter pylori eradication on reducing the incidence of gastric cancer. J Clin Gastroenterol 2008 42 : 279 83.
43. Fukase K, Kato M, Kikuchi S, Inoue K, Uemura N, Okamoto S, Terao S, Amagai K, Hayashi S, Asaka M. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet 2008 372 : 392 7.